Gross margin moved 3027 bp higher
Gross margin changed +3027 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross margin changed +3027 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating margin changed -27400 basis points from the comparable as-filed period.
Operating cash flow changed -94.8% from the comparable as-filed period.
Revenue changed -92.3% from the comparable as-filed period.
Research & development changed -67.4% from the comparable as-filed period.
Cash & equivalents changed -65.5% from the comparable as-filed period.
Gross profit changed +36.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital changed -53.4% from the comparable as-filed period.
Inventory changed +230.4% from the comparable as-filed period.
SBC / revenue changed +1098 basis points from the comparable as-filed period.
Inventory / revenue changed +4650 basis points from the comparable as-filed period.
R&D / revenue changed +662 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -36.5% from the comparable as-filed period.
Current liabilities changed +22.9% from the comparable as-filed period.
Operating income changed +2.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Receivables / revenue changed +645243 basis points from the comparable as-filed period.
Working capital / assets changed -979 basis points from the comparable as-filed period.
Trade receivables changed +15.8% from the comparable as-filed period.
Operating cash-flow margin changed -34658 basis points from the comparable as-filed period.
Total assets changed +11.1% from the comparable as-filed period.
Current assets changed +8.3% from the comparable as-filed period.
Shares outstanding changed +3.2% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes.
Current ratio changed -11.9% from the comparable as-filed period.
Net income changed -0.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.